MyAverix Finance
US · Healthcare
Filana Therapeutics, Inc. (FLNA)
Biotechnology
Filana Therapeutics, Inc. (FLNA) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-28, reported P/E ratio is 18.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for FLNA
Filana Therapeutics, Inc. (FLNA) — FAQ
What is FLNA's P/E ratio?
The price-to-earnings (P/E) ratio for Filana Therapeutics, Inc. (FLNA) is 18.00 (data as of 2026-03-28).
Does Filana Therapeutics, Inc. pay a dividend?
Dividend yield is not available in the current snapshot for Filana Therapeutics, Inc. (FLNA). Check the MyAverix Finance app for the latest dividend data.
What sector is Filana Therapeutics, Inc. in?
Filana Therapeutics, Inc. (FLNA) is classified in the Healthcare sector (Biotechnology industry).
What exchange is FLNA listed on?
FLNA is listed on US.
What is Filana Therapeutics, Inc.'s net margin?
Filana Therapeutics, Inc. (FLNA) reports a net margin of 0.0% (data as of 2026-03-28).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.